Clinical Trials at City of Hope National Medical Center

As of September 2026, 52 paid clinical trials are recruiting at City of Hope National Medical Center, located at 1500 DUARTE RD, DUARTE, CA 91010-3012, phone (626) 256-4673 in Duarte, California. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 1, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

52 clinical trials at City of Hope National Medical Center

·Clear filters·

Get a weekly email when new trials open in Duarte, CA.

ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

for Advanced/Metastatic Solid Tumors

Sites in Duarte, Irvine +4 more locations

Sponsor: Adagene Inc

Sex: All·Age: 18+

Code: NCT05405595·Phase 1, Phase 2·Recruiting·Listed Jun 2022

Apply to this trial

A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers

for Oral Squamous Cell Carcinoma

Sites in Duarte +3 more locations

Sponsor: Privo Technologies

Sex: All·Age: 18 - 100

Code: NCT05893888·Phase 2, Phase 3·Recruiting·Listed Jun 2023

Apply to this trial

BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS

for AML, Adult Recurrent

Sites in Duarte +5 more locations

Sponsor: BlueSphere Bio, Inc

Sex: All·Age: 18 - 70

Code: NCT06704152·Phase 1, Phase 2·Recruiting·Listed Nov 2024

Apply to this trial

A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors

for Advanced Cancer

Sites in Duarte +2 more locations

Sponsor: Proviva Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06190886·Phase 1·Recruiting·Listed Jan 2024

Apply to this trial

Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal Cancer

for Colorectal Neoplasms

Sites in Duarte, La Jolla +4 more locations

Sponsor: Surgimab

Sex: All·Age: 18+

Code: NCT03659448·Phase 3·Recruiting·Listed Sep 2018

Apply to this trial

A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

for Acute Myeloid Leukemia

Sites in Duarte +2 more locations

Sponsor: Edgewood Oncology Inc.

Sex: All·Age: 18+

Code: NCT04243785·Phase 1·Recruiting·Listed Jan 2020

Apply to this trial

Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study

for Advanced Clear Cell Renal Cell Carcinoma

Sites in Duarte, Orange +4 more locations

Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All·Age: 18+

Code: NCT05361720·Phase 2·Recruiting·Listed May 2022

Apply to this trial

Childhood Cancer Survivor Study

for Cancer

Sites in Duarte, Orange +25 more locations

Sponsor: St. Jude Children's Research Hospital

Sex: All·Age: All ages·Accepts healthy volunteers

Code: NCT01120353·Recruiting·Listed May 2010

Apply to this trial

Open-label of Loncastuximab Tesirine (ADCT-402) in Relapsed/Refractory Marginal Zone Lymphoma

for Marginal Zone Lymphoma

Sites in Duarte +3 more locations

Sponsor: University of Miami

Sex: All·Age: 18+

Code: NCT05296070·Phase 2·Recruiting·Listed Mar 2022

Apply to this trial

A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Duarte +2 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT07581002·Phase 2, Phase 3·Recruiting·Listed May 2026

Apply to this trial

A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

for Small Cell Lung Cancer

Drug: ABBV-706

Sites in Duarte, Irvine +30 more locations

Sponsor: AbbVie

Sex: All·Age: 18+

Code: NCT07365241·Phase 3·Recruiting·Listed Jan 2026

Apply to this trial

To Access the Safety and Effects of Intravenous Administration of VIR-5818 Alone and in Combination With Pembrolizumab in Adult Participants With Locally Advanced or Metastatic HER2-Expressing Cancers

for Locally Advanced or Metastatic HER2-Expressing Cancers

1 location in Duarte

Sponsor: Vir Biotechnology, Inc.

Sex: All·Age: 18+

Code: NCT05356741·Phase 1, Phase 2·Recruiting·Listed May 2022

Apply to this trial